30 days to first decision for reviewed manuscripts only
19 days to first decision for all manuscripts
72 days from submission to acceptance
15 days from acceptance to publication
Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1
Immunotherapy is currently under investigation in B3 Thymoma (TB3) and Thymic Carcinoma (TC). PD-L1 expression has been evaluated on a limited number of patients with selected antibodies. We aimed to analyze c...
Citation: Biomarker Research 2019 7:28